Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.780
-0.200 (-5.03%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $7.26 million as of July 10, 2026. Its market cap has decreased by -32.46% in one year.
Market Cap
7.26M
Enterprise Value
6.68M
1-Year Change
-32.46%
Ranking
Category
Stock Price
$3.78
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $7.26M, a decrease of -98.95%. That is a compound annual growth rate of -56.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.26M | -30.79% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioRestorative Therapies | 9.13M |
| Immuron | 8.84M |
| Imunon | 8.82M |
| MetaVia | 8.16M |
| Kairos Pharma | 8.11M |
| Jupiter Neurosciences | 8.01M |
| Can-Fite BioPharma | 7.88M |
| TransCode Therapeutics | 7.80M |